Cargando…
Fibrolamellar hepatocellular carcinoma: current clinical perspectives
Fibrolamellar carcinoma (FLC) is a variant of hepatocellular carcinoma (HCC), which comprises ∼1%–9% of all HCCs. Although FLC is a variant of HCC, it is distinct from HCC in that it most often affects younger patients (10–35 years of age) with no underlying liver disease. FLC often presents with va...
Autores principales: | Lafaro, Kelly J, Pawlik, Timothy M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918295/ https://www.ncbi.nlm.nih.gov/pubmed/27508204 http://dx.doi.org/10.2147/JHC.S75153 |
Ejemplares similares
-
Mixed fibrolamellar hepatocellular carcinoma
por: Limaiem, Faten, et al.
Publicado: (2021) -
Fibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular Carcinoma
por: Riggle, Kevin M., et al.
Publicado: (2016) -
Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver
por: Gummadi, Jyotsna, et al.
Publicado: (2023) -
Metastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas
por: Villa, Nicolas A., et al.
Publicado: (2015) -
Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event
por: Abdelhamed, Walaa, et al.
Publicado: (2022)